Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

前列腺MRI靶向活检阴性患者的后续癌症检测率低，临床意义前列腺癌罕见，尤其PI-RADS 3组未检出癌症。基于PI-RADS分类、PSA密度和DRE结果的风险分层管理可减少重复活检需求。 对于PI-RADS 3–5级病变的男性患者，在MRI引导的活检结果为阴性后的最佳随访方案仍存在 ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...

Prostate specific antigen testing as disease surveillance and monitoring five years after definitive therapy for localized prostate cancer. Relative risk of HTN and major cardiovascular events ...

An artificial intelligence system slightly outperformed radiologists using PI-RADS at detecting clinically significant prostate cancer. A trained artificial intelligence (AI) system discriminated ...

Survival impact of initial local therapy selection for men under 60 with high risk prostate cancer. Prostate cancer (PCa) in 696 hypogonadal men with and without long-term testosterone therapy (TTh): ...

Can active surveillance of prostate cancer be conducted without biopsies? While patients on active surveillance undergo periodic prostate-specific antigen (PSA) and tumor burden assessments, which ...